Lupin aims to launch new products across geographies this fiscal
"Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market and commercialise our…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
FEEDBACK TO FDD Conclave 2019
FDD Conclave 2019, Dr Ramesh Jhawar, Ajanta Pharma , Sapna Ramesh, Indoco Remedies,
ravikumar n, MSN Labortories, ulhas Dhuppad,…
Lupin receives US FDA approval for Phenylephrine and Ketorolac Intraocular Solution
Lupin’s Phenylephrine and Ketorolac Intraocular Solution, 1 per cent 0.3 per cent is the generic version of Omidria Intraocular…
Lupin receives tentative US FDA approval for Mirabegron ER Tablets
Lupin’s Mirabegron ER Tablets, 25 mg and 50 mg, is a generic version of Myrbetriq Extended Release Tablets, 25 mg and 50 mg, of…
Lupin appoints Yugesh Goutam as President – Global HR
Goutam has a track record of developing and sustaining scalable leading edge HR systems/practices for large scale businesses…
Lupin receives FDA approvals for generic Vfend tablets and Vfend oral suspension
Voriconazole Tablets and Voriconazole Oral Suspension are generic equivalents of PF Prism C.V's Vfend Tablets and Vfend Oral…
Lupin announces closure of US FDA audits for its Mandideep and Aurangabad facilities
The US FDA had conducted audits at Lupin’s Mandideep facility from February 8-19, 2016 and its Aurangabad facility from January…
IPA announces new office bearers
The IPA, initially formed by eight national companies in November 1999 has now 20 research-based national pharmaceutical companies…
Lupin launches generic Femhrt tabs in the US
The drug is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal…
Lupin launches generic insomnia drug in the US
This is the first product launched from GAVIS pipeline with 180 days exclusivity